Exhibit G

 Audited Financial Statements for the Fiscal Years ended June 30, 1997 and
1998




INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
                                                                    Page
   Consolidated Financial Statements:                              Number

     Independent Auditors' Report                                            
                                   
     Consolidated Balance Sheets at June 30, 1998 and 1997            

     Consolidated Statements of Operations for the years               
     ended June 30, 1998, 1997 and 1996                              
     
     Consolidated Statements of Changes in Shareholders'
     Equity for the years ended June 30, 1998, 1997 			 
     and 1996                                                        
                   
     Consolidated Statements of Cash Flows for the years               
     ended June 30, 1998, 1997 and 1996                              

     Notes to Consolidated Financial Statements                      

All schedules have been omitted because the required information is not 
applicable or not present in amounts sufficient to require submission of the 
schedule, or because the information required is included in the consolidated 
financial statements or the notes thereto.











INDEPENDENT AUDITORS' REPORT

The Board of Directors and Shareholders
BioTechnica International, Inc.:


We have audited the consolidated financial statements of BioTechnica 
International, Inc. and subsidiary (the "Company") as listed in the 
accompanying index. These consolidated financial statements are the 
responsibility of the Company's management.  Our responsibility is to express 
an opinion on these consolidated financial statements based on our audits.

We conducted our audits in accordance with generally accepted auditing 
standards.  Those standards require that we plan and perform the audit to 
obtain reasonable assurance about whether the financial statements are free 
of material misstatement.  An audit includes examining, on a test basis, 
evidence supporting the amounts and disclosures in the financial statements.  
An audit also includes assessing the accounting principles used and significant 
estimates made by management, as well as evaluating the overall financial 
statement presentation.  We believe that our audits provide a reasonable basis 
for our opinion.

In our opinion, the consolidated financial statements referred to above present
fairly, in all material respects, the financial position of BioTechnica 
International, Inc. and subsidiary as of June 30, 1998 and 1997, and the 
results of their operations and their cash flows for each of the years in the 
three-year period ended June 30, 1998, in conformity with generally accepted 
accounting principles.



                                        			KPMG PEAT MARWICK LLP
Indianapolis, Indiana
July 17, 1998




                       BIOTECHNICA INTERNATIONAL, INC.
                        CONSOLIDATED BALANCE SHEETS
                         (in thousands of dollars)

                                                   June 30,          June 30,
            ASSETS                                    1998              1997  
     

                                                                
Current assets:
  Cash and cash equivalents                        $   353           $   207
  Accounts receivable, less allowance for doubtful
     accounts of $97                                 9,458             7,068
  Inventories                                        7,761             8,330
  Prepaid expenses and other current assets            139               130
       Total current assets                         17,711            15,735
               
Net property, plant and equipment                    8,040             9,316

Goodwill and other assets, net                       7,879             8,385
     Total assets                                  $33,630           $33,436


    LIABILITIES AND SHAREHOLDERS' EQUITY

Current liabilities:
  Borrowings under line of credit                  $ 7,700           $10,900
  Borrowings from affiliates-current                 3,600                --
  Accounts payable                                     489               721
  Accrued liabilities                                2,936             1,669
  Due to affiliates                                    244               115
     Total current liabilities                      14,969            13,405
 
Borrowings from affiliates long-term                 6,761             5,261
Other noncurrent liabilities                           431               295
     Total liabilities                             $22,161           $18,961

Shareholders' equity:                    
  Preferred stock, Class A, 900,000 shares 
    Outstanding (involuntary liquidation value of
    $9 million at June 30, 1998 and 1997)           $    9          $      9
  Common stock, 103,094,737 and 104,094,737 shares
    outstanding at June 30, 1998 and June 30, 1997,
    respectively                                     1,031              1,041
  Additional paid-in capital                        20,823             20,823
  Accumulated deficit                              (10,299)            (7,303)
  Treasury stock                                       (95)               (95)
     Total shareholders' equity                    $11,469            $14,475

Commitments (note 12)

     Total liabilities and shareholders' equity    $33,630            $33,436



See accompanying notes to consolidated financial statement





                        BIOTECHNICA INTERNATIONAL, INC.
                     CONSOLIDATED STATEMENTS OF OPERATIONS
               (in thousands of dollars, except per share amounts)


                                   ---------Years Ended June 30,-----------
                                   1998              1997              1996

                                                          
Net sales:
  Domestic                      $18,047           $17,004          $ 17,151   
  Export-Affiliates               2,984             2,977             1,489    
  Export-Other                      309               104               127    
                                 21,340            20,085            18,767 

Cost of goods sold               14,158            12,319            12,990  
 
  Gross margin                    7,182             7,766             5,777

Operating expenses:   
  Sales and marketing             4,710             4,163             4,203  
  Warehouse and distribution      1,331             1,316             1,196    
  General and administrative      2,677             2,569             2,473   
  Amortization of goodwill          499               499               499     
                                  9,217             8,547             8,371

     Operating loss              (2,035)             (781)           (2,594)

Other income (expense):
  Interest expense                 (966)             (880)             (832) 
  Gain (loss) on disposition 
      of fixed assets              (225)               13               405    
  Other                             231               208               321  


  Loss before income taxes       (2,995)           (1,440)           (2,700)

  Income tax expense (benefit)        1                 9               (15)  

     Net loss                   $(2,996)         $ (1,449)         $ (2,685)  

Net loss per common share       $  (.04)         $   (.02)         $  (0.03)   

      

See accompanying notes to consolidated financial statements





                       BIOTECHNICA INTERNATIONAL, INC.
        CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY    
                 (in thousands of dollars, except share data)

                             Preferred Stock                        Additional
                           Class A Non-Voting    Common Stock         Paid-In 
                           Shares   Par Value  Shares    Par Value    Capital   

                                                       
Balance June 30, 1995      700,000      $ 7  115,418,788   $1,154     $18,893

Issuance of Preferred
  Stock                    200,000        2           --       --       1,998
Net loss for Fiscal 1996        --       --           --       --          --

Balance June 30, 1996      900,000      $ 9  115,418,788   $1,154     $20,891

Repurchase of common shares     --       --  (11,324,051)    (113)        (68)
    
Net loss for Fiscal 1997        --       --           --       --          --
  
Balance June 30, 1997      900,000      $ 9  104,094,737   $1,041     $20,823
         
Net loss for Fiscal 1998        --       --           --       --          --

Repurchase of common shares     --       --   (1,000,000)     (10)         --

Balance June 30, 1998      900,000      $ 9  103,094,737   $1,031     $20,823



                                                                      Total
                                  Treasury Stock      (Accumulated Shareholders'
                                 Shares   Par Value      Deficit)     Equity

                                                        
Balance June 30, 1995            (39,160)     $(95)      $(3,169)   $ 16,790

Issuance of Preferred Stock           --        --            --       2,000
              
Net loss for Fiscal 1996              --        --        (2,685)     (2,685)
 
Balance June 30, 1996            (39,160)     $(95)       (5,854)   $ 16,105
 
Repurchase of common shares           --        --            --        (181)
 
Net loss for Fiscal 1997              --        --        (1,449)     (1,449)

Balance June 30, 1997            (39,160)     $(95)      $(7,303)   $ 14,475
 
Net loss for Fiscal 1998              --        --        (2,996)     (2,996)

Repurchase of common shares           --        --            --         (10)

Balance June 30, 1998            (39,160)     $(95)     $(10,299)     11,469


See accompanying notes to consolidated financial statements




                        BIOTECHNICA INTERNATIONAL, INC.
                     CONSOLIDATED STATEMENTS OF CASH FLOWS
                           (in thousands of dollars)

                                                      Years Ended June 30,      
                                                  1998        1997       1996

                                                            
Cash Flow from Operating Activities:
  Net loss                                    $ (2,996)   $  (1,449) $ (2,685)
  Adjustments to reconcile net loss
     to net cash used in operating activities:
     Depreciation                                  940          954       903   
     Amortization                                  499          499       499   
     (Gain) loss on disposition of fixed assets    225          (13)     (405)  
     
  Changes in assets and liabilities:
     Accounts receivable                        (2,390)         896      (186)  
     Inventories                                   569       (2,354)      951   
     Other assets                                   (2)          87        27 
     Accounts payable and Accrued
       liabilities, and Due to affiliates      	 1,300	        (124)     (178)

  Net cash provided by (used in)
	  operating activities                         (1,855)      (1,504)   (1,074)
  

Cash Flow from Investing Activities:
  Acquisition of property, plant
     and equipment                                (130)        (600)   (1,527)
  Proceeds from asset sales                        241           65     1,078   
    
 Net cash provided by (used in)                  
       investing activities                        111         (535)     (449)  


Cash Flow from Financing Activities:
  Net borrowing(repayment) under line of credit (3,200)       2,400      (700)
  Proceeds (payment) of long-term debt  
     to affiliates                               1,500        2,000    (2,065) 
  Proceeds (payment) of short-term debt  
     to affiliates                               3,600       (2,060)    2,175   
  Payments on long-term debt and 
     notes payable                                  --         (107)      (92)
  Repurchase of common stock                       (10)        (181)       --  
  Issuance of Class A Preferred Stock               --           --     2,000  

 Net cash provided by 
       financing activities                      1,890        2,052     1,318  
       
Net increase (decrease) in
         cash and cash equivalents                 146           13      (205)

Cash and cash equivalents at
    beginning of year                          $   207    $     194    $  399 

Cash and cash equivalents at
    end of year                                $   353    $     207    $  194 
          


See accompanying notes to consolidated financial statement



 

                            BIOTECHNICA INTERNATIONAL, INC.
                     NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


1.  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

A.  Business
BioTechnica International, Inc. and its subsidiary, LG Seeds, Inc. (the 
"Company"), sell corn, soybean, alfalfa and other agricultural seed to 
dealers, distributors and farmers through its seed operations.  The Company 
operates in a twelve-state region centered in the Midwestern United States.  
Sales are generally made on open account to customers.  Because of the 
geographic concentration of the Company's customers in the Midwest, it is 
significantly dependent upon the weather and market conditions in its market 
areas.  In addition, industry sales levels are dependent upon factors 
resulting from governmental agriculture policies and farm programs.

As of June 30, 1998, approximately 95% of the common stock and 100% of the 
Preferred Stock of the Company is owned by Limagrain Genetics Corporation 
("LG Corp."), which is controlled by Groupe Limagrain Holding ("Limagrain") 
of Chappes, France.

B.  Principles of Consolidation
The consolidated balance sheets as of June 30, 1998 and 1997, and statements of 
operations for the three years ended June 30, 1998, include the Company and its 
wholly-owned subsidiary, LG Seeds, Inc.  All significant intercompany 
balances and transactions have been eliminated in consolidation.

C.  Revenue Recognition
Sales of seed products are recorded upon shipment, reduced by a reserve for 
estimated returns and discounts.

D.  Research and Development Costs
Although the Company has no significant internal research and development 
effort, it has access to research conducted by LG Corp. and other Limagrain 
affiliates.  The cost of this expertise is paid to LG Corp. in the form of 
royalties on products sold.

E.  Advertising
The Company expenses all advertising in the period incurred.  Advertising 
expenses for Fiscal 1998, 1997, and 1996 were $166,000, $133,000, and $80,000, 
respectively.

F.  Cash and Cash Equivalents
Cash and cash equivalents consist of cash in banks and short-term investments 
with original maturities of three months or less.

G.  Inventories
Inventories consist primarily of seed products and supplies.  Seed product 
inventory is valued at the lower of average cost by crop year or market.  
Supply inventory is valued at the lower of cost (using the first-in, 
first-out method) or market. Gains or losses, if any, on commodity 
hedging transactions are included as a component of inventory.

H.  Derivatives
The Company has contractual commitments with seed growers for payments based on 
the local commodity prices for soybeans and wheat.  To mitigate the impact of 
fluctuations in commodity prices on inventory costs, the Company attempts from 
time to time to hedge these commitments by using Chicago Board of Trade 
futures contracts for the respective crops.  The Company matches these 
futures contracts to its purchases of inventory, closing out the futures 
contracts as payments are made to the seed growers and recognizing the gains 
and losses as a component of the product cost in cost of sales. There were 
no open futures contracts at either June 30, 1998 or 1997.

I.  Property, Plant and Equipment
Property, plant and equipment are recorded at cost and are depreciated using 
the straight-line method over the estimated useful lives of the assets.  
Depreciable lives for asset classes are:

                      Land improvements                 15 years
                      Buildings and improvements        15 to 32 years
                      Machinery and equipment           3 to 20 years
              



J.  Goodwill 
Goodwill is being amortized using the straight-line method over a period of 20 
years. The Company evaluates the existence of goodwill impairment on the basis 
of whether the goodwill is fully recoverable from projected, undiscounted 
net cash flows.
 
K.  Income Taxes
The Company utilizes the asset and liability method of accounting for income 
taxes whereby deferred tax assets and liabilities are recognized for the future 
tax consequences attributable to differences between the financial statement 
carrying amounts of existing assets and liabilities and their respective tax 
bases.  Deferred tax assets and liabilities are measured using enacted tax 
rates expected to apply to taxable income in the years in which those 
temporary differences are expected to be recovered or settled. The effect on 
deferred tax assets and liabilities of a change in tax rates is recognized in 
income in the period that includes the enactment date.

The Company files a Federal consolidated tax return with other corporations 
controlled by LG Corp. The related tax sharing agreement provides that 
consolidated Federal income tax is allocated among profitable companies.  
Companies with operating losses receive benefits in the future by 
effectively offsetting taxable income against prior operating losses.

L.  Loss Per Common Share
Loss per common share has been computed by dividing the loss applicable to 
common shareholders by the weighted-average number of common shares 
outstanding.  Net loss has been increased by current year cumulative 
preferred stock dividends (whether or not declared) to arrive at loss 
applicable to common shareholders.  The Company has no dilutive potential 
common shares.

M.  Fair Value of Financial Instruments
Carrying amounts of cash and cash equivalents, accounts receivable, accounts 
payable, accrued liabilities, and due to affiliates-current, approximate fair.  
The Company's borrowings under its Line of Credit are at variable interest 
rates tied to market rates and, accordingly, the Company considers the fair 
value to be the same as the carrying value.  The estimated fair value 
of Borrowings from Affiliates-long-term, based on borrowing rates currently 
available to the Company on bank loans with similar terms and maturities would 
be $5,919,000.

N. Use of Estimates
Management of the Company has made a number of estimates and assumptions 
related to the reporting of assets and liabilities and the disclosure of 
contingent assets and liabilities to prepare these financial statements in 
conformity with generally accepted accounting principles.  
Actual results could differ from these estimates.

2.  INVENTORIES
Inventories at June 30, 1998 and 1997 are as follows:

                                                (in thousands of dollars)
                                                  1998              1997   
                    
     Finished seed                             $ 4,473           $ 4,666      
     Unfinished seed                             2,594             2,955      
     Supplies and other                            694               709       
        Total inventories                      $ 7,761           $ 8,330       

"Finished seed" consists of bagged product, ready for sale, net of reserves 
for obsolescence.  "Unfinished seed" consists of bulk product not yet bagged 
and the cost associated with the seed crop planted in the spring of the 
applicable fiscal year.  "Supplies and other" consists of foundation seed, 
unused bags, pallets and other supply items.

3.  PROPERTY, PLANT AND EQUIPMENT
Property, plant and equipment at June 30, 1998 and 1997 are as follows:

                                                (in thousands of dollars)
                                                  1998              1997    

     Land and improvements                     $   577          $    768  
     Buildings and improvements                  7,869             8,185      
     Machinery and equipment                     5,399             5,312   
     Construction in progress                       13                52     
                                               $13,858           $14,317    
 
     Less accumulated depreciation               5,818             5,001 
       Net property, plant and  
         equipment                             $ 8,040           $ 9,316 



4. LOSS PER SHARE

Loss per share was calculated as follows:      (in thousands of dollars)
   
                                             1998          1997          1996   
   
     Net loss                            $ (2,996)     $ (1,449)     $ (2,685)
     Current year cumulative preferred                  
         stock dividends (undeclared)        (675)         (675)         (608)
     Net loss available for common
         shares                            (3,671)       (2,124)       (3,293)

     Weighted average shares outstanding 103,650,098  114,635,033    15,379,628

     Net loss per common share              (0.04)        (0.02)        (0.03)

5.  GOODWILL AND OTHER ASSETS

Goodwill and other assets consist of the following:
                                                (in thousands of dollars)
                                                 1998               1997
    Goodwill                                  $ 9,966            $ 9,966
    Amortization of goodwill                   (2,173)            (1,674)   
        Net goodwill                          $ 7,793            $ 8,292      
    Deposits and other                             86                 93       
        TOTAL                                 $ 7,879            $ 8,385       
 
6.  LINE OF CREDIT AND NOTE PAYABLE

The Company has a revolving credit arrangement with its principal bank 
("Line of Credit") whereby the Company can borrow up to $12,000,000 based on 
a borrowing base formula and subject to certain limitations in availability.  
This Line of Credit, which expires December 31, 1998, bears interest (at 
the Company's option) based upon (i) the Bank Prime Loan rate, (ii) the 
London Interbank Offered Rate ("LIBOR") index or (iii) the Bank Offered Rate.  
Borrowings under this Line of Credit are secured by the inventory and accounts 
receivable of the Company and its subsidiary and by the guarantees of 
Limagrain and LG Corp.  The maximum and average amounts outstanding under 
this Line of Credit during the year ended June 30, 1998 were $10,900,000 and 
$6,177,000, respectively.  The weighted average interest rate during Fiscal 
1998 was 6.92%.

7.  BORROWINGS FROM AFFILIATES

Borrowings from affiliates at June 30, 1998 and 1997 were as follows:
                                                 (in thousands of dollars)

                                                     1998              1997
    Current:
    Limagrain Genetics Corp.
       Due on demand at an annual interest        $ 3,000           $    --
         rate of 6.5%                              
       Due on demand at an annual interest
         rate of 5%                                   600                --
       Total borrowings from affiliates-current   $ 3,600           $    --    

    Long-term:
    Limagrain Genetics Corp.
       Due July 1, 2000 at an annual interest     $ 1,500           $    --
         rate of 6.5%                              
       Due July 1, 2000 at an annual interest
         rate of 5%                                 5,261             5,261 
       Total borrowings from affiliates-long-term $ 6,761           $ 5,261

In addition to these notes at June 30, 1998 and 1997, the Company owes 
affiliates $244,000 and $115,000, respectively, for current items.
   
8.  CAPITAL STOCK

Authorized shares of stock include: 150,000,000 shares of common stock; 
11,100,000 shares of Class A common; 11,100,000 shares of Class B common; 
and 2,000,000 shares of Class A Preferred.

As of June 30, 1998 and 1997, there were only two classes of stock issued and 
outstanding:  common stock and Class A Preferred Stock.

On November 30, 1995, the Company retired a long-term note of $2,000,000 in 
exchange for $2,000,000 of the Company's Class A Preferred Stock.

On June 6, 1997, the Company repurchased and retired 11,324,051 shares of its 
common stock from a shareholder at $0.016 per share.  This common stock 
represented approximately 9.8% of the total common stock.  The price of 
$0.016 per share was substantially below the then-current market price and 
net book value per share.

On February 2, 1998, the Company repurchased and retired 1,000,000 shares of 
its common stock from a shareholder at $0.01 per share.  This common stock 
represented approximately 1.0% of total common stock outstanding on that 
date.  The price of $0.01 per share was substantially below the then-current 
market price and net book value per share.


The Class A Preferred Stock of the Company (all of which is owned by LG Corp.) 
pays a cumulative dividend of $.75 per share per year when declared by the 
Board of Directors.  No such dividend has been declared by the Board of 
Directors.  Pursuant to the terms and conditions of the Company's Class A 
Preferred Stock, should any dividend be declared or paid on the common stock 
of the Company, the holders of Class A Preferred Stock would be entitled to 
receive dividends at a rate per share equal to that of the common stock in 
addition to their preferred dividends.  As of June 30, 1998 and 1997, the 
cumulative amount of undeclared dividends on the Class A Preferred Stock 
was $2,425,000 and $1,750,000, respectively.

9.  STOCK OPTION PLAN

The Company has reserved 1,500,000 shares of common stock for issuance under an 
incentive stock option plan.  During Fiscal 1996, all outstanding options 
were either (i) repurchased by the Company or (ii) determined to have expired. 
The cancellation of these options resulted in a reduction of general and 
administrative expense of $150,000 during Fiscal 1996.  As of June 30, 1998 
and 1997, there were no options outstanding.

10.  RETIREMENT PLAN

The Company participates in a 401(k) savings retirement plan sponsored by 
LG Corp.  The plan covers substantially all full-time employees of the 
Company with at least one year of service.  Vesting occurs over a five-year 
period at 20% per year.  Employees may contribute up to the lesser of 15% of 
their salary or an amount determined annually by Federal income tax 
regulations.  Company contributions may consist of a basic amount for all 
covered employees, a matching contribution for a portion of employee 
contributions, and a potential additional discretionary contribution.

Company contributions under the plan were $168,207, $177,064, and $82,145, for 
Fiscal 1998, Fiscal 1997, and Fiscal 1996, respectively.

11.  INCOME TAXES

On June 30, 1998 and 1997, the Company had pre-acquisition net operating loss 
carryforwards of approximately $1,360,000 and $1,496,000, respectively, 
which expire at a rate of $136,000 per year through 2008. The Company had 
post-acquisition net operating loss carryforwards of approximately $14,886,000 
and $13,332,000 on June 30, 1998 and 1997, respectively, which expire through 
2018. 

The components of income tax expense (benefits) are as follows:
                                           (in thousands of dollars)  
                                     1998              1997             1996 
                
  Federal                            $ --              $ --             $(28)
  State                                 1                 9               13   
  Total                              $  1              $  9             $(15)   

The actual income tax benefit differed from the expected income tax benefit 
(computed by applying the applicable U.S. Federal corporate income tax rate 
of 34% to loss before income taxes) as follows: 
                                            (in thousands of dollars)
                                     1998              1997             1996

Computed "expected" tax benefit   $(1,018)            $(490)           $(933)  
Amortization of goodwill              170               170              170   
State income taxes, net of
   Federal benefit                     --                 6                9    
Alternative minimum tax                --                --              (28)   
Other                                (324)               24             (250)   
Change in valuation allowance       1,173               299            1,017    
   Total                           $    1             $   9           $  (15)  

The tax effects of temporary differences that give rise to significant portions 
of the deferred tax assets and liabilities at June 30, 1998 and 1997 are 
presented below.
                                                     (in thousands of dollars)

                                                       1998             1997
Deferred tax assets:
  Net operating loss carryforward
   (Pre-acquisition)                                 $   530        $    583   
  Net operating loss carryforward
   (Post-acquisition)                                  5,804          5,199    
  Allowance for doubtful accounts                         38             38    
  Allowance for inventory valuation                      179            121    
  Accrued compensation, sales allowances
   and other expenses                                    827            295  
       Total gross deferred tax assets               $ 7,378        $ 6,236   
       Valuation allowance                            (6,792)        (5,623)   

  Total deferred tax assets                              586            613

Deferred tax liability:
  Difference between basis of fixed
   assets for book and tax purposes                   $ (586)       $ (613)
   
  Net deferred tax assets                             $   --        $   -- 
                                  
The change in the deferred tax valuation allowance was an increase of 
$1,173,000 in Fiscal 1998 compared to an increase of $299,000 in Fiscal 1997, 
and an increase of $1,017,000 in Fiscal 1996.

At June 30, 1998 and June 30, 1997, the amount of valuation allowance, which if 
realized would result in a reduction of goodwill, aggregated $530,000, and 
$583,000, respectively.

12.  COMMITMENTS

The Company leases various real and personal property under non-cancelable 
operating leases which expire through 2002.  Rental expenses charged to 
operations were $638,407, $614,321, and $465,000 for the years ended 
June 30, 1998, 1997 and 1996, respectively.  Future annual minimum 
rentals are $573,915, $432,917, $181,506, $46,468, and $739, for Fiscal 1999 
through 2003, respectively.

13.  RELATED PARTIES

The Company has access to the Limagrain germplasm.  The cost to access this 
germplasm is paid to LG Corp. as royalties on corn and soybean units sold.  
Costs incurred for corn royalties were approximately $87,000, $71,000, and 
$94,000 for Fiscal 1998, 1997 and 1996, respectively.  The Company accrued 
or paid $31,000, $44,000, and $50,000 to LG Corp. for royalties on soybean 
genetics for Fiscal 1998, 1997 and 1996, respectively.

The Company has agreements with affiliated companies that provide for certain 
administrative and management services.  Combined costs incurred under 
these agreements were $400,000, $300,000, and $320,000 for Fiscal 1998, 1997 
and 1996, respectively.  Fees for these arrangements are negotiated annually 
by management and approved by the Board of Directors.

The Company sells seed to various affiliated companies in Europe primarily 
under production contracts.  These contracts are negotiated annually and are 
based on market pricing and quantities determined by the affiliates' 
requirements.  Export sales to affiliates amounted to $2,984,000 for Fiscal 
1998, $2,977,000 for Fiscal 1997, and $1,489,000 for Fiscal 1996.

During Fiscal 1996, the Company repurchased 70,000 stock options from officers 
and directors for $3,400. The repurchase of the options, with exercise prices 
between $1.31 and $3.50 per share, resulted in a reduction of approximately 
$66,000 in long-term liabilities.  The net result was a reduction of general 
and administrative expenses of $62,000.

14. SUPPLEMENTAL CASH FLOW INFORMATION

Cash paid for interest aggregated approximately $1,074,000, $880,000 and 
$728,000 for Fiscal 1998, 1997, and 1996, respectively.

15.  LIQUIDITY

The Company has incurred net operating losses and negative cash flow from 
operations for Fiscal 1998, 1997, and 1996.  The Company's current line of 
credit expires on December 31, 1998, at which time management expects to 
renew this credit facility.

Management believes that subsequent to the events described below in "Note 17. 
Subsequent Events", that Limagrain and LG Corp. will recapitalize the Company 
to make additional capital resources available and take steps to improve the 
operations and cash flow.  At this time, specific plans and actions are not 
known.

16. OTHER INCOME AND EXPENSE

Included in other income and expense are $123,000, $95,000, and $68,000 in 
finance charge income on customer accounts for Fiscal 1998, 1997, and 1996, 
respectively.  Also included in other income and expense for Fiscal 1996 is 
$94,000 of gain on the disposal of AgriBioTech, Inc. common stock received 
during Fiscal 1995 by the Company as part of the proceeds from the disposal 
of its Scott Seed Company operations. 

17. SUBSEQUENT EVENTS

On September 21, 1998, the Company received a letter from LG Corp. notifying 
the Company of LG Corp.'s intention to cash out the minority stockholders of 
the Company via a short form merger effected pursuant to Section 253 of the 
General Corporation Law of the State of Delaware (the "DGCL").  The 
consideration to be paid to the minority stockholders of the Company in such 
merger is $0.05 per share.

Under the DGCL, because LG Corp. owns more than 90% of the Company, no action 
will be required of the board of directors of the Company or the stockholders 
of the Company (other than LG Corp. acting through its board of directors), 
for the merger to become effective.  Also, as a "short form" merger, the 
board of directors of the Company had no right to a role, nor did they have a 
role, in negotiating the cash-out price, and the Company's directors have made 
no determination, nor are they required to make a determination, with 
respect to the fairness of the cash-out price.

The merger is expected to be consummated prior to December 31, 1998, or as soon 
as practicable thereafter.  Under the DGCL, minority stockholders of the 
Company who do not wish to accept the consideration of $0.05 per share and 
who follow the procedures set forth in Section 262 of the DGCL will be 
entitled to have their shares of common stock appraised by the Delaware Court
of Chancery and to receive payment in cash of the "fair value" of such shares.  
Prior to the consummation of the merger, LG Corp. reserves the right to 
cancel the merger for any reason, including without limitation if (i) any 
stockholder	of the Company seeks to enjoin the merger or (ii) in LG Corp.'s 
judgment, the anticipated cost of the merger would be materially increased 
by the number of stockholders of the Company seeking their appraisal remedy.